Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

active_not_recruiting133%
completed133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
completednot_applicable

Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer

NCT05058196
active_not_recruitingnot_applicable

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

NCT00185744
unknownphase_3

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

NCT04046159

Clinical Trials (3)

Showing 3 of 3 trials
NCT05058196Not Applicable

Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer

Completed
NCT00185744Not Applicable

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Active Not Recruiting
NCT04046159Phase 3

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Unknown

All 3 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
3